Sign In
News Digest /
Income Statements
Income Statements
08:12am, Wednesday, Aug 13, 2025
Perspective Therapeutics, Inc. (NYSE: ISR) - quick read on what's happening inside
Straight to the point: the company is advancing multiple clinical programs and investing heavily in manufacturing capacity and R&D. That progress is driving a sharp increase in expenses and cash burn, though the ba...
08:11am, Wednesday, Aug 13, 2025
Instil Bio, Inc. (NASDAQ: TIL) - concise operational and income-statement snapshot
Quick financial snapshot (amounts per 10‑Q are in thousands):
* Cash and cash equivalents (6/30/2025): $7,688; cash, cash equivalents and restricted cash-end of period: $7,838 (vs $10,635 at 12/31/2024).
* Marketab...
08:10am, Wednesday, Aug 13, 2025
Quick snapshot - Charlotte's Web Holdings, Inc. (OTCBB: CWBHF)
All dollar amounts below are reported in thousands, except share and per‑share data, unless otherwise noted.
Key facts & headline numbers (Q2 2025 / Six months 2025)
- Revenue: $12,806 (Q2 2025) vs $12,289 (Q2 2024) - +4.2%; Six month...
08:09am, Wednesday, Aug 13, 2025
ProMIS Neurosciences Inc. (PINK: ARFXF) - quick read on what's happening inside the company and what the income statement says.
Snapshot - what's happening now
The company has aggressively stepped up clinical spending to advance its lead program PMN310 (Phase 1b PRECISE‑AD). Management reports p...
08:08am, Wednesday, Aug 13, 2025
SBC Medical Group Holdings Incorporated (NASDAQ: PTWOW) - Snapshot
Straight to the point: quarter showed shrinking revenue and profit margins, heavy related‑party dependence, strong cash position and one‑time gains that boosted non‑operating income. Management is buying stock back but disclosed m...
08:07am, Wednesday, Aug 13, 2025
Aura Biosciences, Inc. (NASDAQ: AURA) - What's happening inside
Short version: the company accelerated clinical and manufacturing work on its lead VDC candidate belzupacap sarotalocan (bel‑sar), funded that activity with a May 16, 2025 follow‑on offering, and materially increased its cash and equ...
08:06am, Wednesday, Aug 13, 2025
Sagimet Biosciences Inc. (NASDAQ: SGMT) - quick operating & financial snapshot
What's happening inside: management is funding aggressive clinical progression - denifanstat advancing toward Phase 3 (positive Phase 2b data and FDA Breakthrough Therapy designation) while a China partner (Ascletis) r...
08:05am, Wednesday, Aug 13, 2025
Company: SideChannel, Inc. (OTCBB: CLOK)
Quick summary - what's happening inside
* Management is pushing Enclave adoption and expanding cybersecurity services while ramping selling & marketing headcount and RSU-based compensation to retain employees.
* The company issued 4,897,323 shares when RS...
08:05am, Wednesday, Aug 13, 2025
Quick take - Tourmaline Bio, Inc. (NASDAQ: TALS)
What's happening inside: management is ramping clinical activity and spending to advance pacibekitug (IL‑6 inhibitor) across cardiovascular inflammation (TRANQUILITY), thyroid eye disease (spiriTED) and a planned AAA Phase 2. The company reported p...
08:04am, Wednesday, Aug 13, 2025
XOMA Royalty Corporation (NASDAQ: XOMA) - Quick take
What's happening inside: XOMA is executing its royalty-aggregator strategy - buying royalty/milestone streams and making targeted acquisitions (BioInvent, Castle Creek, Pulmokine) while monetizing select Kinnate assets. The company is generatin...
08:03am, Wednesday, Aug 13, 2025
Adaptimmune Therapeutics plc (NASDAQ: ADAP) - Snapshot
Adaptimmune reported Q2 2025 operating results and then executed a major corporate transaction in late July 2025. The company sold its cell‑therapy commercial and late‑stage assets (including TECELRA and lete‑cel) to US WorldMeds, received $5...
08:02am, Wednesday, Aug 13, 2025
DUKE Robotics Corp. (PINK: USDR) - Quick read on what's happening inside
Source: Form 10-Q for quarter ended June 30, 2025. All amounts in USD thousands unless noted.
Key facts & figures
- Revenues (3 months ended 6/30/2025): $143
- Cost of revenues (3 months): $55 - Gross profit (3 months): $88
...
08:01am, Wednesday, Aug 13, 2025
Wilhelmina International, Inc. (NASDAQ: WHLM) - Q2 2025 snapshot
Quick read: revenue growth on a six‑month basis and rising gross billings, but profitability and operating margins compressed in Q2 as personnel and office costs rose; cash fell and receivables increased. Management executed a $0.8...
07:04am, Wednesday, Aug 13, 2025
Xenous Holdings, Inc. (PINK: XITO) - Quarterly snapshot (period ended June 30, 2025)
Short take: Xenous is a non‑operating shell with no revenue, zero cash, and ongoing reliance on advances from its majority shareholder while it completes due diligence on a proposed Malaysia acquisition. Results ...
07:03am, Wednesday, Aug 13, 2025
Quick take - China Automotive Systems, Inc. (NASDAQ: CAAS)
Inside the company: sales are growing and cashflow improved materially in H1 2025 while the business shifts toward electric power steering (EPS). Management is investing more in R&D and completing organizational moves (a proposed redomici...
07:02am, Wednesday, Aug 13, 2025
GivBux, Inc (PINK: GBUX) - quick operating and income-statement snapshot.
Headline summary
GivBux reported revenue growth year-over-year but recorded very large non‑cash losses that drove a steep net loss and widened stockholders' deficit. The company flagged a going concern and material internal...
07:01am, Wednesday, Aug 13, 2025
Snapshot - HG Holdings, Inc. (NASDAQ: STLY)
Straightforward: Q2 2025 showed revenue and profitability improvement driven by higher title volumes and new related‑party management fees, but the company remains small, highly connected to related parties and dependent on non‑cash transactions and equ...
07:01am, Wednesday, Aug 13, 2025
ESSA Pharma Inc. (NASDAQ: EPIX) - Snapshot
What's happening inside the company: ESSA has effectively moved from active clinical development into a wind‑down and strategic exit process. The firm terminated its masofaniten (EPI‑7386) clinical program (announced Oct 31, 2024), is winding down precli...
06:26pm, Tuesday, Aug 12, 2025
Ascent Solar Technologies, Inc. (NASDAQ: ASTI) - What's happening inside
Short version: revenue remains tiny and roughly flat year‑over‑year, the company is cutting some operating costs but increasing R&D and equity compensation, continues to burn cash (~$3.36M YTD), has raised capital via ATM an...
06:25pm, Tuesday, Aug 12, 2025
CO2 Energy Transition Corp. (NASDAQ: NOEMU) - Quick take
This is a blank‑check (SPAC) that closed its IPO on November 22, 2024 and sits largely in a trust account waiting to complete a business combination. The company reported net income for Q2 2025 driven entirely by interest on trust assets, w...
06:25pm, Tuesday, Aug 12, 2025
Vicarious Surgical Inc. (RBOT) - quick read
Short take: the company remains pre-revenue and shrinking costs, but cash runway is tight and the SEC 10‑Q discloses substantial doubt about going concern, material internal control weaknesses, and an active plan with the NYSE to regain listing complian...
06:24pm, Tuesday, Aug 12, 2025
Xenetic Biosciences, Inc. (NASDAQ: XBIO)
Quick summary - what's happening inside
* The company remains pre‑clinical, advancing its DNase oncology program and funding operations largely from legacy royalties and cash on hand.
* Management says existing resources should fund operations for at least...
06:23pm, Tuesday, Aug 12, 2025
Southland posts gross‑profit rebound amid $2.3B backlog but remains loss‑making and highly leveraged
Southland Holdings, Inc. (NYSE: SLND) - Quick read on what's happening inside the company
Source: Southland 10‑Q for quarter ended June 30, 2025. Amounts shown are as reported (amounts in thousands unless noted).
Headline
* Revenue and profitability improved versus the year‑ago period at the gros...
06:22pm, Tuesday, Aug 12, 2025
Syra Health Corp. (NASDAQ: SYRA) - Quick read on what's happening inside
Syra is showing clear operational tightening and margin improvement while still burning cash and facing concentration, governance and going-concern risks. Management reduced headcount and costs, shifted mix from lower-margi...
06:21pm, Tuesday, Aug 12, 2025
Netlist, Inc. (NASDAQ: NLST)
Quick read: Netlist reported Q2 2025 results showing revenue growth vs. Q2 2024, tighter gross margins, lower legal/R&D spend and a smaller quarterly loss. Liquidity improved through a June 2025 registered offering, but working capital is negative, inventories rose sh...
06:20pm, Tuesday, Aug 12, 2025
NexGel, Inc. (NASDAQ: NXGL) - Quick read on what's happening inside
Snapshot: strong top-line growth driven by branded consumer products and the CGN JV, meaningful margin improvement, but the company remains unprofitable, cash is low, and management flags a going-concern risk. The company closed ...
06:18pm, Tuesday, Aug 12, 2025
United States Antimony Corporation (NYSE: UAMY) - Quick read: what's happening inside the company and what the income statement shows.
* Top-line momentum: Q2 2025 revenues $10,525,123 vs Q2 2024 $3,662,977; six‑month revenues $17,525,128 vs $6,735,044.
* Profitability: Q2 2025 gross profit $2,83...
06:17pm, Tuesday, Aug 12, 2025
Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) - Quick read
What's happening inside:
Management is ramping clinical activity for sabirnetug (Phase 2 ALTITUDE-AD enrollment completed March 2025), increasing manufacturing and CRO spend to support the trial and a subcutaneous formulation program. The c...
06:16pm, Tuesday, Aug 12, 2025
HCM II Acquisition Corp. (NASDAQ: HONDU) - quick read on what's happening inside
* Company type: blank‑check (SPAC) - formed to acquire/merge with a target (Business Combination Agreement signed with Terrestrial Energy on March 26, 2025).
* Primary business activity to date: hold IPO proceeds in...
06:16pm, Tuesday, Aug 12, 2025
M-tron Industries, Inc. (NYSEMKT: MPTI)
Quick take: M-tron reported continued top-line growth driven by defense and avionics demand but is seeing margin pressure from new-product manufacturing and tariffs. Liquidity is strong, backlog is expanding, and management is investing in R&D and equipment...
06:14pm, Tuesday, Aug 12, 2025
Corner Growth Acquisition Corp. (NASDAQ: COOL) - Quick read
What's happening inside: the company remains a blank‑check/SPAC that has not commenced operating activities. Its proposed business combination with Noventiq was terminated (July 3, 2024). The company is delisted from Nasdaq (suspension e...
06:14pm, Tuesday, Aug 12, 2025
Intrusion Inc. (OTCMKTS: INTZ) - Quick read
Snapshot
* Revenue growth: $1,873 (Q2 2025) vs $1,460 (Q2 2024) - +28%; Six months: $3,648 vs $2,591 - +41%.
* Gross profit: $1,431 (Q2) - gross margin ~76.4%.
* Net loss: $(2,042) (Q2 2025); six months $(4,140).
* Cash & equivalents: $4,689 (as of 6/30...
06:13pm, Tuesday, Aug 12, 2025
Corner Growth Acquisition Corp. 2 (PINK: TRON) - What's happening inside
The company is a blank‑check/SPAC with no operating revenues. It holds trust cash for a business combination, has been delisted from Nasdaq (effective Aug 14, 2024), is running on sponsor support for expenses, and management...
06:12pm, Tuesday, Aug 12, 2025
Quick take - Siebert Financial Corp. (NASDAQ: SIEB)
What's happening inside: management is pushing technology (Retail Platform) and music/entertainment expansions (acquired Gebbia Media; bought music masters from BMLG). The firm completed a $100M shelf (effective June 9, 2025) and set up an ATM p...
06:11pm, Tuesday, Aug 12, 2025
Rapid Micro Biosystems, Inc. (NASDAQ: RPID) - Quick inside look
Management is shrinking operating costs, signing a global distribution deal and adding a secured debt facility to extend runway - but the company remains unprofitable with ongoing operating cash burn. Below are the key facts, income-...
06:10pm, Tuesday, Aug 12, 2025
Beyond Air, Inc. (NASDAQ: XAIR) - Quick read
What's happening inside: commercial rollout of the LungFit® PH is generating early revenue and international distribution deals, management is cutting operating spend, but the company remains loss-making with tight liquidity and an expensive loan facil...
06:09pm, Tuesday, Aug 12, 2025
NeuroPace, Inc. (NASDAQ: NPCE) - quick read on what's happening inside the company and the income statement.
Snapshot - facts & figures (as reported, all $ in thousands unless noted)
* Q2 2025 revenue: $23,520 (up 22% vs Q2 2024); 6‑month revenue: $46,044 (up 23% YoY).
* Q2 2025 gross profit: $18...
06:07pm, Tuesday, Aug 12, 2025
ClearPoint Neuro, Inc. (NASDAQ: CLPT) - Quick internal read
What's happening inside: management is scaling commercialization (SmartFrame OR, Prism laser, OS 3.0) and biologics/drug‑delivery services while investing heavily in R&D and commercial headcount. In May 2025 the company completed a smal...
06:06pm, Tuesday, Aug 12, 2025
Mineralys Therapeutics, Inc. (NASDAQ: MLYS) - quick read
Snapshot - what's happening inside
* Company is a clinical‑stage biotech focused on lorundrostat (aldosterone synthase inhibitor) across uncontrolled/resistant hypertension, CKD and obstructive sleep apnea.
* Pivotal trials Launch‑HTN and ...
06:05pm, Tuesday, Aug 12, 2025
Knightscope, Inc. (NASDAQ: KSCP) - Quick read on what's happening inside
All numbers from the company's Form 10‑Q for quarter ended June 30, 2025 (amounts presented in the filing are in thousands except share and per‑share data).
Snapshot - situation at a glance
* Cash and cash equivalents (6/30/...
